首页> Vaccine> Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.

Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.

导出 LinkOut

翻译打印收藏纠错

第一作者： Tanja,Opriessnig

第一单位： The Roslin Institute and The Royal (Dick) School of Veterinary Studies, University of Edinburgh, Midlothian, UK; Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA. Electronic address: Tanja.Opriessnig@roslin.ed.ac.uk.

作者： Tanja,Opriessnig ^[1] ; Priscilla F,Gerber ^[2] ; Chao-Ting,Xiao ^[2] ; Patrick G,Halbur ^[2] ; Shannon R,Matzinger ^[3] ; Xiang-Jin,Meng ^[3]

作者单位： The Roslin Institute and The Royal (Dick) School of Veterinary Studies, University of Edinburgh, Midlothian, UK; Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA. Electronic address: Tanja.Opriessnig@roslin.ed.ac.uk. ^[1] Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA. ^[2] Department of Biomedical Sciences and Pathobiology, Center for Molecular Medicine and Infectious Diseases, College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA. ^[3]

关键词 Genotypes Mutant PCV2 PCV2 Porcine circovirus Vaccination Vaccine efficacy